ArticleBMC medical imaging2025
An optimal graph convolutional vision neural network with explainable feature optimization for improved skin cancer detection.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite advancements in skin cancer diagnosis procedures, misclassification rates in early detection remain high, leading to delayed treatments and reduced survival rates. Existing manual diagnostic methods are often prone to inter-observer variability and human error, while traditional machine learning models struggle with imbalanced datasets and insufficient feature generalization. To address these challenges, this work proposes an Optimal Skin Cancer Classification Network (OSCC-Net), developed on the International Skin Imaging Collaboration-2019 (ISIC-2019) dataset. The model integrates an Adaptive Minority Over-Sampling Procedure (AMOP) to balance under-represented lesion classes, ensuring robust learning for minority lesion classes. The Stochastic Neighbourhood T-Distilling driven Score-Weighted Class Activation Mapping (STND-SWCAM) framework is introduced for feature analysis. It performs fine-grained lesion localization and interpretability, enabling better understanding of decisions. In the feature selection stage, a Grizzly Bear Fat Increase Optimizer with Density-Based Spatial Neighbourhood Discovery Algorithm (GBFIO-DSNDA) is employed to enhance discriminative feature extraction by eliminating redundant and noisy features. Finally, classification is performed using a Graph Convolutional Vision Neural Network (GC-VNN), which leverages spatial dependencies among lesion attributes for improved decision-making. Experimental evaluation reveals that, OSCC-Net achieves 98.32% accuracy, 98.43% precision, 98.40% recall, and 98.39% F1-Score, marking a substantial improvement over baselines shown in our experiments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.